FLC
KDNY

Fifth Lane Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Fifth Lane Capital’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$384K – 227
2023
Q2 		$384K Buy
+10,000
New +$384K 0.11% 35